United States
Germany
Japan
United Kingdom
China
Anti-NKG2A(monalizumab biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
Primary Antibodies
Anti-HTRA1(galegenimab biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
Anti-CCR2(plozalizumab biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
Anti-CD166(praluzatamab biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
